At the close of business on 09 May 2022, Morten Opstad, Chair of the Board of IDEX Biometrics ASA, held the following voting rights in IDEX, for the purpose of the Extraordinary General Meeting on 12 May 2022:
Total 158,029,594 shares or 15,61% of the share capital and votes, consisting of the following:
- Proxy to represent and vote for 36,788,284 shares or 3,64% of the share capital, including shares held by Mr Opstad and close relations
- Proxy with voting instructions for 121,241,310 shares or 11,97% of the share capital.
For further information contact:
Marianne Bøe, Head of Investor Relations
Tel: + 47 918 00186
Brett L Perry, U.S. Investor Relations
Tel: + 1 214 272 0070
About IDEX Biometrics
IDEX Biometrics ASA (OSE: IDEX and Nasdaq: IDXBA) is a leading provider of fingerprint identification technologies offering simple, secure and personal touch-free authentication for all. We help people make payments, prove their identity, gain access to information, unlock devices or gain admittance to buildings. We invent, engineer, and commercialize these secure and safe yet incredibly user-friendly solutions. Our total addressable market represents a fast growing multi-billion-unit opportunity.
For more information, visit www.idexbiometrics.com and follow @IDEXBiometrics.
This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act